These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25553446)

  • 1. Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria.
    Kaminsky YG; Tikhonova LA; Kosenko EA
    Front Biosci (Landmark Ed); 2015 Jan; 20(1):173-97. PubMed ID: 25553446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35).
    Kaminsky YG; Marlatt MW; Smith MA; Kosenko EA
    Exp Neurol; 2010 Jan; 221(1):26-37. PubMed ID: 19751725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death.
    Cha MY; Han SH; Son SM; Hong HS; Choi YJ; Byun J; Mook-Jung I
    PLoS One; 2012; 7(4):e34929. PubMed ID: 22514691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
    Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
    J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
    Arias C; Montiel T; Quiroz-Báez R; Massieu L
    Exp Neurol; 2002 Jul; 176(1):163-74. PubMed ID: 12093093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monomers, oligomers, and fibrils of amyloid-β inhibit the activity of mitoBK
    Kravenska Y; Nieznanska H; Nieznanski K; Lukyanetz E; Szewczyk A; Koprowski P
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183337. PubMed ID: 32380169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging promotes amyloid-β peptide induced mitochondrial dysfunctions in rat brain: a molecular link between aging and Alzheimer's disease.
    Sinha M; Behera P; Bhowmick P; Banerjee K; Basu S; Chakrabarti S
    J Alzheimers Dis; 2011; 27(4):753-65. PubMed ID: 21876248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    Caspersen C; Wang N; Yao J; Sosunov A; Chen X; Lustbader JW; Xu HW; Stern D; McKhann G; Yan SD
    FASEB J; 2005 Dec; 19(14):2040-1. PubMed ID: 16210396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol enhances Abeta42-induced neuronal cell death through mitochondrial dysfunction.
    Lee DY; Lee KS; Lee HJ; Jung HY; Lee JY; Lee SH; Youn YC; Seo KM; Lee JH; Lee WB; Kim SS
    FEBS Lett; 2008 Dec; 582(30):4185-90. PubMed ID: 19026642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoxyeicosatrienoic acids pretreatment improves amyloid β-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes.
    Sarkar P; Zaja I; Bienengraeber M; Rarick KR; Terashvili M; Canfield S; Falck JR; Harder DR
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H475-84. PubMed ID: 24285116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
    Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
    Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction.
    Jin H; Liu T; Wang WX; Xu JH; Yang PB; Lu HX; Sun QR; Hu HT
    Neurochem Int; 2010 Feb; 56(3):417-23. PubMed ID: 19941922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids variations in amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease.
    Atamna H
    J Bioenerg Biomembr; 2009 Oct; 41(5):457-64. PubMed ID: 19806442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
    Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
    Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.
    Manczak M; Mao P; Calkins MJ; Cornea A; Reddy AP; Murphy MP; Szeto HH; Park B; Reddy PH
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S609-31. PubMed ID: 20463406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
    Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
    J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.